Christopher Rogers is listed as an executive officer and director on 6 SEC Form D filings by 2 issuers between Oct 2014 and Sep 2025: DataBiologics, Inc. (Mesa, AZ — other health care — 2022–2025; $815K reported sold to 16 investors) and Next Alternative Inc. (Chandler, AZ — oil and gas — 2014).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $815K sold in total.
Listed alongside Jay Bowen (5 shared filings), Leah Braddell (3 shared filings), Luke Malanga (3 shared filings), Gerard Malanga (2 shared filings), Hugh James (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Christopher Rogers and found 10 differences: 4 bankruptcy cases name the subject or team members; Christopher Rogers appears on 1 deal that stopped filing before reaching its target; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.